Companies: 10,795·Total market cap: $144.5T
Invitae Corporation

Invitae Corporation

NVTAQOTCHealthcare
$0.00
$-0.00(-25.00%)
Market Cap$85948
P/E Ratio
52W High
52W Low
Overview

Invitae Corporation(NVTAQ)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · NVTAQ · 截至 Jun 9, 2026

关键指标

EPS (TTM)nvtaq eps ttm · nvtaq earnings per shareEarnings history
PE Ratio (TTM)nvtaq pe ratio ttm · nvtaq price to earningsPE Ratio deep dive
Revenue (TTM)nvtaq revenue ttm · nvtaq annual revenueFull revenue history
Dividend Yield不分红does nvtaq pay dividends · nvtaq dividend yieldDividend history
Shares Outstandingnvtaq shares outstanding · nvtaq floatShares outstanding history
Next EarningsTBAnvtaq earnings date · nvtaq next earningsEarnings history

关于 Invitae Corporation

CEOKenneth D. Knight
IPO DateFeb 12, 2015
Employees1,700
CountryUS

Invitae Corporation (NVTAQ) operates as a medical genetics enterprise, striving to advance healthcare outcomes by furnishing crucial genetic information to individuals across the United States, Canada…

what is invitae corporation · nvtaq stock overview · invitae corporation company profile · who is invitae corporation ceo · nvtaq OTC · invitae corporation headquarters · invitae corporation business segments

关于股票概览与关键数据

Invitae Corporation(NVTAQ)是 Medical - Diagnostics & Research 行业的 Healthcare 类公司,于 Feb 12, 2015 在 OTC 上市。截至最近交易日,NVTAQ 股价为 $0.00,市值约为 $85,948。过去12个月累计回报 —,年初至今回报 —。

常见问题

截至最近一个交易日,Invitae Corporation(NVTAQ)股价为 $0.00,在 OTC 上市,52周区间为 $1.00 – $4.00。

NVTAQ 最新股价NVTAQ quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议